Bio-Techne (TECH) Stock: Buy, Sell, or Hold?
$72.80
-0.02 (-0.03%)
▼
5d:
+0.1%
30d:
+0.44%
90d:
+0.87%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (50%)
Quality Score
52/100
Position
EXTENDED
30-Day Fair Range
$72.50 – $72.73
Position: EXTENDED
Forward P/E & Valuation
42.8x
STRETCHED
vs 31.8x historical avg
Wall Street Target
$70.50
-3.2% vs target
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$72.63 / $72.88
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: TECH shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When TECH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$30.06
Based on -6.4% avg growth
INTRINSIC VALUE TODAY
$18.67
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: TECH is currently trading at $72.80, which is considered extended relative to its 30-day fair value range of $72.50 to $72.73. From a valuation perspective, the stock is trading at a premium (Forward PE: 42.8) compared to its historical average (31.8). At these levels, the market is pricing in 10.4% annual earnings growth.
Technical Outlook: Technically, TECH is in a strong uptrend. The price is currently testing key support at $72.63. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, TECH is in a strong uptrend. The price is currently testing key support at $72.63. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$72.50 -
$72.73
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
49.5%
Trading Range & Key Levels
30-Day Trading Range
$72.50 -
$72.73
Current vs Trading Range
EXTENDED
Support Level
$72.63
Resistance Level
$72.88
Current Trend
Strong Uptrend
Technical data as of
Nov 11, 2026
Quantitative Signal Breakdown
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($70.50)
- BULLISH: Expecting earnings turnaround to 10.4% growth with 4.6% revenue growth
- WARNING: Composite score 52/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
42.82
Wall Street Target
$70.50
(-3.2%)
Revenue Growth (YoY)
4.6%
Earnings Growth (YoY)
-25.0%
Profit Margin
14.0%
Valuation Premium vs History
+10.4% premium
PE vs Historical
42.8 vs 31.8
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+10.4%
(market-implied from PE analysis)
1-Year Target
$80.37
(+10%)
2-Year Target
$88.73
(+22%)
3-Year Target
$97.96
(+35%)
3-Yr Target (if PE normalizes)
(PE: 43→32)
PE COMPRESSION
$72.74
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 42.8, Growth: -16.8%)
$53.07
(+-27%)
Base:
(SPY PE: 19.9, Growth: -16.8%)
$24.61
(-66%)
Bear:
(PE: 16.9, Growth: -16.8%)
$20.92
(-71%)
📈
Valuation based on Current Earnings
Forward PE: 35.71 | Forward EPS (Implied): $2.04
Bull Case
$87.91
(+21%)
Analyst growth 15.0%, PE expands to 37.5
Base Case
$72.80
(0%)
Market implied 0.0%, PE stable at 35.7
Bear Case
$55.69
(-24%)
Severe decline -15.0%, PE contracts to 32.1
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share TECH Analysis
Share this live TECH analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (TECH)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 5, 2026
Daily AI digest
AI Retail Discussion Summary:
Trader on StockTwits expresses a bullish outlook on $TECH, mentioning the growing short interest and Merck's BO-Offer as potential catalysts.
Key Retail Themes:
Short interest
Merck's BO-Offer
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 1:53 AM ET
Data refreshes hourly during market hours. Next update: 2:53 AM
Data refreshes hourly during market hours. Next update: 2:53 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TECH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RVMD
Revolution Medicines Inc |
STRONG BUY
25 analysts |
$261 | 53 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
21 analysts |
$95 | 41 HOLD |
|
JANX
Janux Therapeutics Inc |
STRONG BUY
18 analysts |
$32 | 51 HOLD |
|
SNDX
Syndax Pharmaceuticals I… |
STRONG BUY
12 analysts |
$35 | 60 HOLD |
|
ACHV
Achieve Life Sciences Inc |
STRONG BUY
12 analysts |
$14 | 56 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive TECH Research Pages
